In our multivariate logistic regression analysis, we found two significant predictors for differentiating Xp11.2/TFE3 RCC from pRCC: younger age and relatively higher peak enhancement were more likely to be present in Xp11.2/TFE3 RCC. Here, TFE3 is linked to renal cell carcinoma.